201 related articles for article (PubMed ID: 16832055)
1. Details of Toll-like receptor:adapter interaction revealed by germ-line mutagenesis.
Jiang Z; Georgel P; Li C; Choe J; Crozat K; Rutschmann S; Du X; Bigby T; Mudd S; Sovath S; Wilson IA; Olson A; Beutler B
Proc Natl Acad Sci U S A; 2006 Jul; 103(29):10961-6. PubMed ID: 16832055
[TBL] [Abstract][Full Text] [Related]
2. Signalling of toll-like receptors.
Brikos C; O'Neill LA
Handb Exp Pharmacol; 2008; (183):21-50. PubMed ID: 18071653
[TBL] [Abstract][Full Text] [Related]
3. Specificity in Toll-like receptor signalling through distinct effector functions of TRAF3 and TRAF6.
Häcker H; Redecke V; Blagoev B; Kratchmarova I; Hsu LC; Wang GG; Kamps MP; Raz E; Wagner H; Häcker G; Mann M; Karin M
Nature; 2006 Jan; 439(7073):204-7. PubMed ID: 16306937
[TBL] [Abstract][Full Text] [Related]
4. Simultaneous deletion of MyD88 and Trif delays major histocompatibility and minor antigen mismatch allograft rejection.
McKay D; Shigeoka A; Rubinstein M; Surh C; Sprent J
Eur J Immunol; 2006 Aug; 36(8):1994-2002. PubMed ID: 16874736
[TBL] [Abstract][Full Text] [Related]
5. Distinct roles of TIR and non-TIR regions in the subcellular localization and signaling properties of MyD88.
Nishiya T; Kajita E; Horinouchi T; Nishimoto A; Miwa S
FEBS Lett; 2007 Jul; 581(17):3223-9. PubMed ID: 17583698
[TBL] [Abstract][Full Text] [Related]
6. Subversion of Toll-like receptor signaling by a unique family of bacterial Toll/interleukin-1 receptor domain-containing proteins.
Cirl C; Wieser A; Yadav M; Duerr S; Schubert S; Fischer H; Stappert D; Wantia N; Rodriguez N; Wagner H; Svanborg C; Miethke T
Nat Med; 2008 Apr; 14(4):399-406. PubMed ID: 18327267
[TBL] [Abstract][Full Text] [Related]
7. MAPPIT analysis of early Toll-like receptor signalling events.
Ulrichts P; Tavernier J
Immunol Lett; 2008 Mar; 116(2):141-8. PubMed ID: 18221795
[TBL] [Abstract][Full Text] [Related]
8. Pathological role of Toll-like receptor signaling in cerebral malaria.
Coban C; Ishii KJ; Uematsu S; Arisue N; Sato S; Yamamoto M; Kawai T; Takeuchi O; Hisaeda H; Horii T; Akira S
Int Immunol; 2007 Jan; 19(1):67-79. PubMed ID: 17135446
[TBL] [Abstract][Full Text] [Related]
9. Type 1 cytokine/chemokine production by mouse NK cells following activation of their TLR/MyD88-mediated pathways.
Sawaki J; Tsutsui H; Hayashi N; Yasuda K; Akira S; Tanizawa T; Nakanishi K
Int Immunol; 2007 Mar; 19(3):311-20. PubMed ID: 17289654
[TBL] [Abstract][Full Text] [Related]
10. Toll-like receptor-dependent activation of antigen-presenting cells affects adaptive immunity to Helicobacter pylori.
Rad R; Brenner L; Krug A; Voland P; Mages J; Lang R; Schwendy S; Reindl W; Dossumbekova A; Ballhorn W; Wagner H; Schmid RM; Bauer S; Prinz C
Gastroenterology; 2007 Jul; 133(1):150-163.e3. PubMed ID: 17631139
[TBL] [Abstract][Full Text] [Related]
11. Toll-like receptor recognition regulates immunodominance in an antimicrobial CD4+ T cell response.
Yarovinsky F; Kanzler H; Hieny S; Coffman RL; Sher A
Immunity; 2006 Oct; 25(4):655-64. PubMed ID: 17000122
[TBL] [Abstract][Full Text] [Related]
12. The adaptor protein CARD9 is essential for the activation of myeloid cells through ITAM-associated and Toll-like receptors.
Hara H; Ishihara C; Takeuchi A; Imanishi T; Xue L; Morris SW; Inui M; Takai T; Shibuya A; Saijo S; Iwakura Y; Ohno N; Koseki H; Yoshida H; Penninger JM; Saito T
Nat Immunol; 2007 Jun; 8(6):619-29. PubMed ID: 17486093
[TBL] [Abstract][Full Text] [Related]
13. Toll-like receptors and adaptor molecules in liver disease: update.
Seki E; Brenner DA
Hepatology; 2008 Jul; 48(1):322-35. PubMed ID: 18506843
[TBL] [Abstract][Full Text] [Related]
14. Elucidation of toll-like receptor and adapter protein signaling in vascular dysfunction induced by gram-positive Staphylococcus aureus or gram-negative Escherichia coli.
Cartwright N; McMaster SK; Sorrentino R; Paul-Clark M; Sriskandan S; Ryffel B; Quesniaux VF; Evans TW; Mitchell JA
Shock; 2007 Jan; 27(1):40-7. PubMed ID: 17172979
[TBL] [Abstract][Full Text] [Related]
15. Differential induction of MyD88- and TRIF-dependent pathways in equine monocytes by Toll-like receptor agonists.
Figueiredo MD; Vandenplas ML; Hurley DJ; Moore JN
Vet Immunol Immunopathol; 2009 Jan; 127(1-2):125-34. PubMed ID: 19019456
[TBL] [Abstract][Full Text] [Related]
16. Evidence for licensing of IFN-gamma-induced IFN regulatory factor 1 transcription factor by MyD88 in Toll-like receptor-dependent gene induction program.
Negishi H; Fujita Y; Yanai H; Sakaguchi S; Ouyang X; Shinohara M; Takayanagi H; Ohba Y; Taniguchi T; Honda K
Proc Natl Acad Sci U S A; 2006 Oct; 103(41):15136-41. PubMed ID: 17018642
[TBL] [Abstract][Full Text] [Related]
17. Sorting out Toll signals.
Fitzgerald KA; Chen ZJ
Cell; 2006 Jun; 125(5):834-6. PubMed ID: 16751092
[TBL] [Abstract][Full Text] [Related]
18. MAPPIT analysis of TLR adaptor complexes.
Ulrichts P; Peelman F; Beyaert R; Tavernier J
FEBS Lett; 2007 Feb; 581(4):629-36. PubMed ID: 17258210
[TBL] [Abstract][Full Text] [Related]
19. The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling.
O'Neill LA; Bowie AG
Nat Rev Immunol; 2007 May; 7(5):353-64. PubMed ID: 17457343
[TBL] [Abstract][Full Text] [Related]
20. Structure, function and regulation of the Toll/IL-1 receptor adaptor proteins.
Watters TM; Kenny EF; O'Neill LA
Immunol Cell Biol; 2007; 85(6):411-9. PubMed ID: 17667936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
